Pharma Industry News

Atyr Pharma: Q1 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Friday reported a loss of $10.8 million in its first quarter. The San Diego-based company said it had a loss of 11 cents per share. The company's shares closed at 56 cents.

ARS Pharma (SPRY) Q4 2025 Earnings Transcript

Monday, March 9, 2026, at 8:30 a.m. ET Chief Executive Officer — Richard Lowenthal Chief Commercial Officer — Eric Karas Chief Financial Officer — Kathleen Scott Need a quote from a Motley Fool analyst? Email [email protected]…

Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible

Houston Business Journal New Jersey-based Bristol Myers Squibb said it would create nearly 500 jobs at the site. HOUSTON — Another pharmaceutical heavyweight is considering Houston for its domestic manufacturing operations, following several…

Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

Pfizer (PFE) trades at $25.75 with a rare 6.66% dividend yield and 9x forward P/E, offering upside. Molina and Halliburton join Pfizer as defensive cash generators with structural edges through pricing power and margin stability. This post may…

This startup wants to make drugs in orbit. If it succeeds, it could transform the space economy

A start-up's plan to run drug experiments and even develop pharmaceuticals in orbit is taking shape. If it works, it could mark a step toward developing new medicines and, ultimately, a burgeoning space-based manufacturing industry. The start-up in…

2 Ways to Play the Big Pharma Patent Cliff

Major pharmaceuticals firms like Pfizer Inc. NYSE: PFE and Novo Nordisk A/S NYSE: NVO have been fighting to spend large sums on smaller companies in the space in recent months (the former of these companies completed an acquisition of weight loss…

Hertfordshire Pharma lands £2.3m Saudi contracts after UKEF steps in to plug working capital gap

That is precisely the bind that Masters Speciality Pharma, a 41-year-old Hertfordshire specialist pharmaceutical company, found itself in last year after winning two sizeable orders from Saudi Arabia worth a combined £2.3 million. The remedy…

Olema Stock: The Market Overreacted To Roche's SERD Failure (NASDAQ:OLMA)

Olema Pharmaceuticals is rated a cautious buy, with upside potential tied to pivotal OPERA-01 Phase 3 trial results expected in fall 2026. Palazestrant differentiates itself as a CERAN with superior mechanistic action, favorable pharmacokinetics…

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next blockbusters. Bristol's deal is unique because…

American Century Small Cap Value Fund Q1 2026 Commentary (Mutual Fund:ASVIX)

The fund's significant overweight in energy, particularly holdings like Crescent Energy, Permian Resources, and Magnolia Oil & Gas, contributed positively as oil prices surged due to Middle East conflict. ASVIX remains underweight health care…

105,950 Orion Corporation A shares converted into B shares

STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 105,950 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 105,950…

Call Them Gamblers or Investors, They're Moving Stocks

Q4 Results 15th May Live: Tata Steel, PowerGrid, Solar, SAIL, Hindustan Copper, Premier Energies, Cochin Shipyard, Godrej, Godfrey Phillips, ITC Hotels, Gland Pharma, SJVN to announce Q4 results, TMPV, HAL, JSW Steel, Apollo Tyres, VMM in focus

Q4 Results Today, May 15, 2026 Live Updates: Find all the latest Q4 results 2026 updates of Aarti Drugs, Aether Industries, Abans Financial Services, Ashapura Intimates Fashion, AKI India, Alacrity Securities, Amber Enterprises India, Alembic…

'Irrational': Judge erupts as Cosette shirks Mayne's $13m legal bill

The courtroom stoush between jilted takeover target Mayne Pharma and its former US suitor, Cosette, has turned even uglier after a judge slammed the American medical giant for making irrational, radical, and counterintuitive arguments about why it…

India's West Asia Trade Declines 28% in April Amid Shipping Disruptions, War Impact

India's trade with the West Asian region experienced a notable contraction for the second consecutive month in April, with both exports and imports declining by over 28%, primarily due to severe shipping disruptions caused by the ongoing conflict…